News
Cigna’s first-quarter report shows strong numbers, but Barclays warns the road ahead could get rocky. Barclays highlights ...
Citigroup (C -0.30%) is one of the best-known banks in the United States and probably the world. But it doesn't have the best ...
Guggenheim has reaffirmed its buy rating on The Cigna Group, setting a target price of $388, making investors grin. The Cigna ...
UBS analyst AJ Rice reaffirmed a “Buy” rating on The Cigna Group (NYSE:CI) with a price target of $390. Rice shared his views ...
Guggenheim analyst Jason Cassorla maintained a Buy rating on Cigna (CI – Research Report) today and set a price target of $388.00. The company’s shares closed yesterday at $31 ...
Hims & Hers Health, Inc. navigates strong growth and partnerships despite rising competitive risks. Click here to read an ...
Wall Street’s worries about a ballooning deficit that threatens America’s status as a safe haven were reflected in a $16 ...
Detailed price information for Onkure Therapeutics Inc (OKUR-Q) from The Globe and Mail including charting and trades.
We recently compiled a list of the 11 Cheap ESG Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where The Cigna Group ... have used the ratings by ...
On Monday, Raymond (NSE: RYMD) James increased its price target on shares of CIGNA (NYSE: CI) to $385 from the previous target of $360, while reiterating a Strong Buy rating on the stock.With a market ...
Cigna’s stock price target increase at Jefferies reflects a vote of confidence in the company’s ability to maintain its strong performance and deliver value to shareholders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results